Construction of trans-fused polycyclic ethers: methodology for the brevetoxins

~%

~%

~%

~%

~%

~88%

~%

~%

~%

~%

~%

~%

~%

~%

~%

~%

~81%

~12%

~%

~%

~%

~%

~%